Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms
Author:
Carretta ChiaraORCID, Parenti Sandra, Bertesi MatteoORCID, Rontauroli SebastianoORCID, Badii Filippo, Tavernari LaraORCID, Genovese ElenaORCID, Malerba MaricaORCID, Papa ElisaORCID, Sperduti SamanthaORCID, Enzo ElenaORCID, Mirabile Margherita, Pedrazzi Francesca, Neroni Anita, Tombari Camilla, Mora Barbara, Maffioli Margherita, Mondini MarcoORCID, Brociner Marco, Maccaferri Monica, Tenedini ElenaORCID, Martinelli Silvia, Bartalucci Niccolò, Bianchi ElisaORCID, Casarini Livio, Potenza Leonardo, Luppi Mario, Tagliafico Enrico, Guglielmelli PaolaORCID, Simoni ManuelaORCID, Passamonti Francesco, Norfo Ruggiero, Vannucchi Alessandro MariaORCID, Manfredini RossellaORCID,
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Grabek J, Straube J, Bywater M, Lane SW. MPN: the molecular drivers of disease initiation, progression and transformation and their effect on treatment. Cells. 2020;9:1901. 2. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Araujo IBO, Berti E, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720–48. 3. Hinshelwood S, Bench AJ, Green AR. Pathogenesis of polycythaemia vera. Blood Rev. 1997;11:224–32. 4. Barbui T, Barosi G, Grossi A, Gugliotta L, Liberato LN, Marchetti M, et al. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica. 2004;89:215–32. 5. Rumi E, Pietra D, Pascutto C, Guglielmelli P, Martínez-Trillos A, Casetti I, et al. Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis. Blood. 2014;124:1062–9.
|
|